Upexi, Inc.: Form 10-Q for the period ended Dec 31, 2022
Filed with the SEC on Feb 15, 2023 and accepted by EDGAR at Feb 15, 2023, 11:37 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-10-01 to 2022-12-31 | $27.1m | us-gaap:Revenues |
| Revenue | 6 months2022-07-01 to 2022-12-31 | $38.6m | us-gaap:Revenues |
| Cost of revenue | 3 months2022-10-01 to 2022-12-31 | $16.8m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2022-07-01 to 2022-12-31 | $22.3m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2022-10-01 to 2022-12-31 | $10.3m | us-gaap:GrossProfit |
| Gross profit | 6 months2022-07-01 to 2022-12-31 | $16.4m | us-gaap:GrossProfit |
| Operating income | 3 months2022-10-01 to 2022-12-31 | −$2.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2022-07-01 to 2022-12-31 | −$5.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-10-01 to 2022-12-31 | $755.3k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-07-01 to 2022-12-31 | −$47.1k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-10-01 to 2022-12-31 | $2.6m | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-07-01 to 2022-12-31 | $72.2k | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2022-10-01 to 2022-12-31 | $0.15 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2022-07-01 to 2022-12-31 | $0.01 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-10-01 to 2022-12-31 | $0.16 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2022-07-01 to 2022-12-31 | $0.01 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-10-01 to 2022-12-31 | 19,030,705 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2022-07-01 to 2022-12-31 | 18,617,164 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2022-07-01 to 2022-12-31 | $3.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2022-07-01 to 2022-12-31 | $184.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-12-31 | $4.5m | us-gaap:Cash |
| Current assets | At period end2022-12-31 | $22.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $76.6m | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $15.1m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2022-12-31 | $36.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001477932-23-001046. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.